⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL665800 | 0.80 | — | — | |
| SCHEMBL7704422 | 0.78 | CYP1B1 (0.32) | — | |
| SCHEMBL29086344 | 0.78 | CYP1B1 (0.32) | — | |
| SCHEMBL16011600 | 0.74 | — | — | |
| SCHEMBL916382 | 0.74 | — | — | |
| SCHEMBL1259823 | 0.74 | — | — | |
| SCHEMBL1680347 | 0.74 | — | — | |
| SCHEMBL735083 | 0.74 | — | — | |
| SCHEMBL289071 | 0.74 | — | — | |
| SCHEMBL245783 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022072448-A1 | METHODS OF PATHOGEN IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TESTING | THE JOHNS HOPKINS UNIVERSITY (US) | 2022-04-07 | — | — | WO | claimed |
| US-RE47084-E1 | Oral medicinal product with modified release of at least one active principle in multimicrocapsular form | FLAMEL IRELAND LIMITED (IE) | 2018-10-16 | — | — | US | claimed |
| EP-1827396-B1 | ORAL MEDICAMENT FOR THE MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE, IN MULTIMICROCAPSULE FORM | FLAMEL IRELAND LTD (IE) | 2016-06-01 | — | — | EP | claimed |
| US-8734850-B2 | Oral medicinal product with modified release of at least one active principle in multimicrocapsular form | FLAMEL TECHNOLOGIES (FR) | 2014-05-27 | — | — | US | claimed |
| US-8377455-B2 | Biosurfactant composition produced by a new Bacillus licheniforms strain, uses and products thereof | PAN-ECO S.A. (LU) | 2013-02-19 | — | — | US | claimed |
| US-8303933-B2 | Multicomponent assemblies having enhanced binding properties for diagnosis and therapy | MALLINCKRODT LLC (US) | 2012-11-06 | — | — | US | claimed |
| US-8257683-B2 | Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly | MALLINCKRODT LLC (US) | 2012-09-04 | — | — | US | claimed |
| US-8246930-B2 | Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly | MALLINCKRODT LLC (US) | 2012-08-21 | — | — | US | claimed |
| US-20110274730-A1 | BIOSURFACTANT COMPOSITION PRODUCED BY A NEW BACILLUS LICHENIFORMS STRAIN, USES AND PRODUCTS THEREOF | PAN-ECO S.R.L. (IT) | 2011-11-10 | — | — | US | claimed |
| EP-2384335-A1 | BIOSURFACTANT COMPOSITION PRODUCED BY A NEW BACILLUS LICHENIFORMIS STRAIN, USES AND PRODUCTS THEREOF | PAN-ECO S.A. (LU) | 2011-11-09 | — | — | EP | claimed |
| EP-1776113-A1 | PHARMACEUTICAL FORMULATION BASED ON ANTIBIOTIC IN MICROCAPSULE FORM | Flamel Technologies (FR) | 2007-04-25 | — | — | EP | claimed |
| US-20060269511-A1 | MULTICOMPONENT ASSEMBLIES HAVING ENHANCED BINDING PROPERTIES FOR DIAGNOSIS AND THERAPY | MALLINCKRODT, INC. (US) | 2006-11-30 | — | — | US | claimed |
| US-7087212-B2 | Multicomponent assemblies having enhanced binding properties for diagnosis and therapy | MALLINCKRODT, INC (US) | 2006-08-08 | — | — | US | claimed |
| WO-2006056711-A2 | ORAL MEDICAMENT FOR THE MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE, IN MULTIMICROCAPSULE FORM | FLAMEL TECHNOLOGIES (FR) | 2006-06-01 | — | — | WO | claimed |
| WO-2006010868-A1 | PHARMACEUTICAL FORMULATION BASED ON ANTIBIOTIC IN MICROCAPSULE FORM | FLAMEL TECHNOLOGIES (FR) | 2006-02-02 | — | — | WO | claimed |
| EP-1465666-A4 | MULTICOMPONENT ASSEMBLIES HAVING ENHANCED BINDING PROPERTIES FOR DIAGNOSIS AND THERAPY | MALLINCKRODT INC (US) | 2005-11-30 | — | — | EP | claimed |
| US-20050196459-A1 | Carvedilol salts, anhydrates and/or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods | FLAMEL TECHNOLOGIES S.A. (US) | 2005-09-08 | — | — | US | claimed |
| EP-1465666-A2 | MULTICOMPONENT ASSEMBLIES HAVING ENHANCED BINDING PROPERTIES FOR DIAGNOSIS AND THERAPY | Mallinckrodt Inc. (US) | 2004-10-13 | — | — | EP | claimed |
| WO-2003015606-A2 | MULTICOMPONENT ASSEMBLIES HAVING ENHANCED BINDING PROPERTIES FOR DIAGNOSIS AND THERAPY | MALLINCKRODT INC. (US) | 2003-02-27 | — | — | WO | claimed |
| US-20030039683-A1 | Multicomponent assemblies having enhanced binding properties for diagnosis and therapy | MALLINCKRODT INC. (US) | 2003-02-27 | — | — | US | claimed |